SCHEMBL26720584

SCHEMBL26720584

Cc1ccc(S(=O)(=O)n2ccc3c(B4OC(C)(C)C(C)(C)O4)cc(C)nc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.44
ELANE P08246 1/20 0.36
PRTN3 P24158 1/20 0.36
MAPT P10636 1/20 0.36
BRD4 O60885 1/20 0.36
PKM P14618 1/20 0.35
HTR6 P50406 3/20 0.35
ATR Q13535 1/20 0.35
ATRIP Q8WXE1 1/20 0.35
RAPGEF4 Q8WZA2 2/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
HPGD P15428 1/20 0.33
ACVR1 Q04771 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
POLB P06746 1/20 0.33
ALDH3A1 P30838 1/20 0.33
HTT P42858 1/20 0.33
NOD1 Q9Y239 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21354067 0.87 L3MBTL1 (0.41) L3MBTL1ELANEPRTN3MAPTBRD4
SCHEMBL1394996 0.83 L3MBTL1 (0.50) L3MBTL1ELANEPRTN3BRD4PKM
SCHEMBL29605448 0.83 L3MBTL1 (0.37) L3MBTL1ELANEPRTN3MAPTPKM
SCHEMBL31324865 0.83 L3MBTL1 (0.50) L3MBTL1ELANEPRTN3BRD4PKM
SCHEMBL28657465 0.83 RAPGEF4 (0.37) L3MBTL1MAPTRAPGEF4HTTGAA
SCHEMBL20918069 0.82 POLB (0.40) L3MBTL1MAPTMEN1KMT2APOLB
SCHEMBL21643732 0.78 HTR6 (0.39) L3MBTL1ELANEPRTN3BRD4PKM
SCHEMBL28657466 0.78 CYP2C19 (0.41) HTR6HPGDMEN1KMT2AHTT
SCHEMBL20576536 0.77 L3MBTL1 (0.36) L3MBTL1ELANEPRTN3PKMHTR6
SCHEMBL30321292 0.77 L3MBTL1 (0.36) L3MBTL1ELANEPRTN3PKMHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
EP-4214214-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-07-26 EP disclosed
CN-116171280-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-05-26 CN disclosed
WO-2022058920-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2022-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS CSNK1D, CSNK1A1, CSNK1G1 L3MBTL1 2390/4885ELANE 4274/4885PRTN3 1496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.